Variant report

Variant	esv3404372
Chromosome Location	chr4:3461704-3464502
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	CHD2	chr4:3463166-3463490	Hela-S3	cervix:	n/a	n/a
2	CHD2	chr4:3464168-3464354	HepG2	liver:	n/a	n/a
3	CTCF	chr4:3463260-3463410	HEEpiC	esophagus:	n/a	n/a
4	E2F4	chr4:3463249-3463437	MCF10A-Er-Src	breast:	n/a	n/a
5	EBF1	chr4:3463376-3463680	GM12878	blood:	n/a	n/a
6	EGR1	chr4:3463291-3463803	MCF-7	breast:	n/a	chr4:3463507-3463521 chr4:3463632-3463642 chr4:3463630-3463643 chr4:3463629-3463644 chr4:3463508-3463521 chr4:3463630-3463643 chr4:3463509-3463519 chr4:3463509-3463520 chr4:3463506-3463516 chr4:3463633-3463642 chr4:3463508-3463521 chr4:3463630-3463643 chr4:3463508-3463521 chr4:3463508-3463521
7	EGR1	chr4:3463095-3463902	ECC-1	luminal epithelium:	n/a	chr4:3463507-3463521 chr4:3463632-3463642 chr4:3463630-3463643 chr4:3463629-3463644 chr4:3463508-3463521 chr4:3463630-3463643 chr4:3463509-3463519 chr4:3463509-3463520 chr4:3463506-3463516 chr4:3463633-3463642 chr4:3463508-3463521 chr4:3463630-3463643 chr4:3463508-3463521 chr4:3463508-3463521
8	EGR1	chr4:3463480-3463713	K562	blood:	n/a	chr4:3463507-3463521 chr4:3463632-3463642 chr4:3463630-3463643 chr4:3463629-3463644 chr4:3463508-3463521 chr4:3463630-3463643 chr4:3463509-3463519 chr4:3463509-3463520 chr4:3463506-3463516 chr4:3463633-3463642 chr4:3463508-3463521 chr4:3463630-3463643 chr4:3463508-3463521 chr4:3463508-3463521
9	EGR1	chr4:3463068-3463914	ECC-1	luminal epithelium:	n/a	chr4:3463507-3463521 chr4:3463632-3463642 chr4:3463630-3463643 chr4:3463629-3463644 chr4:3463508-3463521 chr4:3463630-3463643 chr4:3463509-3463519 chr4:3463509-3463520 chr4:3463506-3463516 chr4:3463633-3463642 chr4:3463508-3463521 chr4:3463630-3463643 chr4:3463508-3463521 chr4:3463508-3463521
10	EGR1	chr4:3463420-3463715	GM12878	blood:	n/a	chr4:3463507-3463521 chr4:3463632-3463642 chr4:3463630-3463643 chr4:3463629-3463644 chr4:3463508-3463521 chr4:3463630-3463643 chr4:3463509-3463519 chr4:3463509-3463520 chr4:3463506-3463516 chr4:3463633-3463642 chr4:3463508-3463521 chr4:3463630-3463643 chr4:3463508-3463521 chr4:3463508-3463521
11	EGR1	chr4:3463109-3463858	MCF-7	breast:	n/a	chr4:3463507-3463521 chr4:3463632-3463642 chr4:3463630-3463643 chr4:3463629-3463644 chr4:3463508-3463521 chr4:3463630-3463643 chr4:3463509-3463519 chr4:3463509-3463520 chr4:3463506-3463516 chr4:3463633-3463642 chr4:3463508-3463521 chr4:3463630-3463643 chr4:3463508-3463521 chr4:3463508-3463521
12	EGR1	chr4:3463507-3463704	GM12878	blood:	n/a	chr4:3463507-3463521 chr4:3463632-3463642 chr4:3463630-3463643 chr4:3463629-3463644 chr4:3463508-3463521 chr4:3463630-3463643 chr4:3463509-3463519 chr4:3463509-3463520 chr4:3463633-3463642 chr4:3463508-3463521 chr4:3463630-3463643 chr4:3463508-3463521 chr4:3463508-3463521
13	ELF1	chr4:3463335-3463807	GM12878	blood:	n/a	chr4:3463506-3463518
14	ELF1	chr4:3463134-3463889	MCF-7	breast:	n/a	chr4:3463506-3463518
15	EP300	chr4:3462963-3463915	ECC-1	luminal epithelium:	n/a	chr4:3463503-3463512
16	EP300	chr4:3463064-3463712	T-47D	breast:	n/a	chr4:3463503-3463512
17	EP300	chr4:3462863-3464003	ECC-1	luminal epithelium:	n/a	chr4:3463503-3463512
18	EP300	chr4:3462917-3463789	MCF-7	breast:	n/a	chr4:3463503-3463512
19	EP300	chr4:3462932-3463859	MCF-7	breast:	n/a	chr4:3463503-3463512
20	EP300	chr4:3463028-3463607	T-47D	breast:	n/a	chr4:3463503-3463512
21	ESR1	chr4:3462786-3463795	ECC-1	luminal epithelium:	n/a	chr4:3463573-3463590 chr4:3463204-3463221 chr4:3462898-3462913
22	ESR1	chr4:3463063-3463626	T-47D	breast:	n/a	chr4:3463573-3463590 chr4:3463204-3463221
23	ESR1	chr4:3463049-3463654	T-47D	breast:	n/a	chr4:3463573-3463590 chr4:3463204-3463221
24	ESR1	chr4:3462706-3463803	ECC-1	luminal epithelium:	n/a	chr4:3463573-3463590 chr4:3463204-3463221 chr4:3462898-3462913
25	ESR1	chr4:3463018-3463693	T-47D	breast:	n/a	chr4:3463573-3463590 chr4:3463204-3463221
26	ESR1	chr4:3462966-3463796	ECC-1	luminal epithelium:	n/a	chr4:3463573-3463590 chr4:3463204-3463221
27	ESR1	chr4:3461747-3462002	T-47D	breast:	n/a	n/a
28	ESR1	chr4:3462628-3463956	ECC-1	luminal epithelium:	n/a	chr4:3463573-3463590 chr4:3463204-3463221 chr4:3462898-3462913
29	ESR1	chr4:3463040-3463661	T-47D	breast:	n/a	chr4:3463573-3463590 chr4:3463204-3463221
30	ESR1	chr4:3463017-3463695	T-47D	breast:	n/a	chr4:3463573-3463590 chr4:3463204-3463221
31	ESR1	chr4:3462551-3463910	ECC-1	luminal epithelium:	n/a	chr4:3463573-3463590 chr4:3463204-3463221 chr4:3462898-3462913
32	ESR1	chr4:3463014-3463761	T-47D	breast:	n/a	chr4:3463573-3463590 chr4:3463204-3463221
33	ESR1	chr4:3462637-3463898	ECC-1	luminal epithelium:	n/a	chr4:3463573-3463590 chr4:3463204-3463221 chr4:3462898-3462913
34	FOS	chr4:3463347-3463547	MCF10A-Er-Src	breast:	n/a	n/a
35	FOS	chr4:3463249-3463450	MCF10A-Er-Src	breast:	n/a	n/a
36	FOXA1	chr4:3463137-3463571	T-47D	breast:	n/a	n/a
37	FOXM1	chr4:3462834-3464004	MCF-7	breast:	n/a	n/a
38	FOXM1	chr4:3462943-3463876	ECC-1	luminal epithelium:	n/a	n/a
39	FOXM1	chr4:3463098-3463837	MCF-7	breast:	n/a	n/a
40	FOXM1	chr4:3462984-3463887	ECC-1	luminal epithelium:	n/a	n/a
41	GABPA	chr4:3463294-3463581	H1-hESC	embryonic stem cell:	n/a	n/a
42	GABPA	chr4:3464180-3464524	H1-hESC	embryonic stem cell:	n/a	n/a
43	GATA3	chr4:3463216-3463721	MCF-7	breast:	n/a	n/a
44	GATA3	chr4:3463008-3463847	MCF-7	breast:	n/a	n/a
45	GATA3	chr4:3463162-3463639	T-47D	breast:	n/a	n/a
46	GATA3	chr4:3462984-3464037	MCF-7	breast:	n/a	n/a
47	GTF2F1	chr4:3463061-3463300	Hela-S3	cervix:	n/a	n/a
48	HA-E2F1	chr4:3462979-3463892	MCF-7	breast:	n/a	chr4:3463507-3463516
49	HDAC2	chr4:3464088-3464437	HepG2	liver:	n/a	n/a
50	HDAC2	chr4:3463021-3463689	MCF-7	breast:	n/a	n/a

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr4:3462498-3462548	H1-hESC	embryonic stem cell:	embryo
2	chr4:3462498-3462548	SAEC	small airway:	n/a
3	chr4:3462498-3462548	HCF	heart:	n/a
4	chr4:3462498-3462548	IMR90	lung:	fetal
5	chr4:3462498-3462548	AG04449	skin:	fetal
6	chr4:3462498-3462548	CMK	blood:	n/a
7	chr4:3462498-3462548	NHBE	bronchial:	n/a
8	chr4:3462498-3462548	RPTEC	kidney:	n/a
9	chr4:3462498-3462548	HMEC	breast:	n/a
10	chr4:3462498-3462548	ProgFib	skin:	n/a
11	chr4:3462498-3462548	T-47D	breast:	n/a
12	chr4:3462498-3462548	U87	brain:	n/a
13	chr4:3462498-3462548	AG10803	skin:	n/a
14	chr4:3462498-3462548	AG04450	lung:	fetal
15	chr4:3462498-3462548	Caco-2	colon:	n/a
16	chr4:3462498-3462548	PFSK-1	brain:	n/a
17	chr4:3462498-3462548	HRPEpiC	eye:	n/a
18	chr4:3462498-3462548	HCPEpiC	choroid plexus:	n/a
19	chr4:3462498-3462548	AG09309	skin:	n/a
20	chr4:3462498-3462548	HEK293	kidney:	embryo
21	chr4:3462498-3462548	GM12891	blood:	n/a
22	chr4:3462498-3462548	K562	blood:	n/a
23	chr4:3462498-3462548	SK-N-SH	brain:	n/a
24	chr4:3462498-3462548	BE2_C	brain:	n/a
25	chr4:3462498-3462548	GM19239	blood:	n/a
26	chr4:3462498-3462548	HRCEpiC	kidney:	n/a
27	chr4:3462498-3462548	AG09319	gingival:	n/a
28	chr4:3462498-3462548	SK-N-MC	brain:	n/a
29	chr4:3462498-3462548	MCF10A-Er-Src	breast:	n/a
30	chr4:3462498-3462548	Hela-S3	cervix:	n/a
31	chr4:3462498-3462548	A549	lung:	n/a
32	chr4:3462498-3462548	HAEpiC	amniotic membrane:	n/a
33	chr4:3462498-3462548	NB4	blood:	n/a
34	chr4:3462498-3462548	NT2-D1	testis:	n/a
35	chr4:3462498-3462548	PrEC	prostate:	n/a
36	chr4:3462498-3462548	SKMC	muscle:	n/a
37	chr4:3462498-3462548	AoSMC	blood vessel:	n/a
38	chr4:3462498-3462548	HepG2	liver:	n/a
39	chr4:3462498-3462548	HNPCEpiC	eye:	n/a
40	chr4:3462498-3462548	MCF-7	breast:	n/a
41	chr4:3462498-3462548	HEEpiC	esophagus:	n/a
42	chr4:3462498-3462548	ECC-1	luminal epithelium:	n/a
43	chr4:3462498-3462548	HL-60	blood:	n/a
44	chr4:3462498-3462548	NH-A	brain:	n/a
45	chr4:3462498-3462548	SK-N-SH_RA	brain:	n/a
46	chr4:3462498-3462548	HCM	heart:	n/a
47	chr4:3462498-3462548	PANC-1	pancreas:	n/a
48	chr4:3462498-3462548	ovcar-3	ovarian:	n/a
49	chr4:3462498-3462548	Hepatocyte	liver:	n/a
50	chr4:3462498-3462548	HUVEC	blood vessel:	n/a

No.	Distal block	Cell Line	Cell type
1	chr4:3464468..3466347-chr4:3532849..3534407,2	MCF-7	breast:
2	chr4:3346041..3348825-chr4:3461682..3464499,2	MCF-7	breast:
3	chr4:3288141..3289800-chr4:3461769..3463366,2	MCF-7	breast:
4	chr4:3110927..3117533-chr4:3461507..3465762,15	MCF-7	breast:
5	chr4:3462844..3463532-chr4:3486166..3487066,3	MCF-7	breast:
6	chr4:3343221..3349626-chr4:3462156..3471133,16	MCF-7	breast:
7	chr4:3462755..3463727-chr4:3486334..3487219,3	MCF-7	breast:
8	chr11:61737950..61740369-chr4:3461504..3464468,2	MCF-7	breast:
9	chr4:3365688..3366496-chr4:3463170..3464043,2	MCF-7	breast:
10	chr4:3462755..3463804-chr4:3486304..3487219,5	MCF-7	breast:
11	chr4:3292471..3295854-chr4:3462941..3467927,8	MCF-7	breast:
12	chr4:3428894..3431544-chr4:3462169..3465013,2	MCF-7	breast:
13	chr4:3076153..3077682-chr4:3463023..3464527,2	MCF-7	breast:
14	chr4:3438186..3441523-chr4:3461903..3464658,4	MCF-7	breast:

Variant related genes	Relation type
DOK7	TF binding region
DOK7	CpG island
ENSG00000163956	chromatin interactions
ENSG00000251075	chromatin interactions
ENSG00000197386	chromatin interactions
ENSG00000159788	chromatin interactions
ENSG00000175920	chromatin interactions

Extended variants
information (count: 124 )
Associated
traits (count: 58 )

Variant overlapped rSNPs/rCNVs (count:124 , 50 per page) page: 1 2 3

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs191420355	chr4:3461727-3461728	Weak transcription Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
2	rs200054941	chr4:3461750-3461751	Weak transcription Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
3	rs1203105	chr4:3461825-3461826	Weak transcription Enhancers	TF binding region Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
4	rs111932056	chr4:3461866-3461867	Weak transcription Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
5	rs185027969	chr4:3461870-3461871	Weak transcription Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
6	rs2091626	chr4:3461900-3461901	Weak transcription Enhancers	TF binding region Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
7	rs575838477	chr4:3461942-3461943	Weak transcription Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
8	rs546522498	chr4:3461943-3461944	Weak transcription Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
9	rs542580025	chr4:3461957-3461958	Weak transcription Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
10	rs528574768	chr4:3461962-3461963	Weak transcription Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
11	rs113596337	chr4:3462063-3462064	Weak transcription Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
12	rs572531747	chr4:3462074-3462075	Weak transcription Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
13	rs544700493	chr4:3462076-3462077	Weak transcription Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
14	rs547324374	chr4:3462082-3462083	Weak transcription Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
15	rs370200351	chr4:3462126-3462127	Weak transcription Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
16	rs116836670	chr4:3462150-3462151	Weak transcription Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
17	rs544350547	chr4:3462154-3462155	Weak transcription Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
18	rs150975826	chr4:3462185-3462186	Weak transcription Enhancers	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
19	rs1076903	chr4:3462194-3462195	Weak transcription Enhancers	TF binding region Chromatin interactive region	3 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
20	rs547014613	chr4:3462196-3462197	Weak transcription Enhancers	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
21	rs140836554	chr4:3462233-3462234	Weak transcription Enhancers	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
22	rs145416785	chr4:3462262-3462263	Weak transcription Enhancers	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
23	rs368893829	chr4:3462360-3462361	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
24	rs532600710	chr4:3462369-3462370	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
25	rs528715859	chr4:3462414-3462415	Bivalent Enhancer Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
26	rs116881258	chr4:3462447-3462448	Bivalent Enhancer Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
27	rs149183522	chr4:3462453-3462454	Bivalent Enhancer Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
28	rs569333494	chr4:3462464-3462465	Bivalent Enhancer Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
29	rs189524195	chr4:3462469-3462470	Bivalent Enhancer Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
30	rs146018601	chr4:3462498-3462499	Bivalent Enhancer Enhancers	CpG island Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
31	rs116609676	chr4:3462499-3462500	Bivalent Enhancer Enhancers	CpG island Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
32	rs376027675	chr4:3462501-3462502	Bivalent Enhancer Enhancers	CpG island Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
33	rs73079073	chr4:3462525-3462526	Bivalent Enhancer Enhancers	CpG island Chromatin interactive region	3 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
34	rs193224376	chr4:3462531-3462532	Bivalent Enhancer Enhancers	CpG island Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
35	rs138904541	chr4:3462540-3462541	Bivalent Enhancer Enhancers	CpG island Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
36	rs369094256	chr4:3462591-3462592	Bivalent Enhancer Enhancers	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
37	rs572494846	chr4:3462609-3462610	ZNF genes & repeats Enhancers Bivalent Enhancer	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
38	rs538204063	chr4:3462637-3462638	ZNF genes & repeats Enhancers Bivalent Enhancer	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
39	rs558130089	chr4:3462664-3462665	ZNF genes & repeats Enhancers Bivalent Enhancer	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
40	rs562838581	chr4:3462674-3462675	ZNF genes & repeats Enhancers Bivalent Enhancer	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
41	rs529260361	chr4:3462789-3462790	ZNF genes & repeats Enhancers Bivalent Enhancer	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
42	rs551006960	chr4:3462842-3462843	Flanking Bivalent TSS/Enh ZNF genes & repeats Enhancers Bivalent Enhancer Flanking Active TSS	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
43	rs373162187	chr4:3462916-3462917	Flanking Bivalent TSS/Enh ZNF genes & repeats Enhancers Bivalent Enhancer Flanking Active TSS	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
44	rs574963821	chr4:3462923-3462924	Flanking Bivalent TSS/Enh ZNF genes & repeats Enhancers Bivalent Enhancer Flanking Active TSS	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
45	rs185182042	chr4:3462940-3462941	Flanking Bivalent TSS/Enh ZNF genes & repeats Enhancers Bivalent Enhancer Flanking Active TSS	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
46	rs190077876	chr4:3462954-3462955	Flanking Bivalent TSS/Enh ZNF genes & repeats Enhancers Bivalent Enhancer Flanking Active TSS	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
47	rs530041167	chr4:3462974-3462975	Flanking Bivalent TSS/Enh ZNF genes & repeats Enhancers Bivalent Enhancer Flanking Active TSS	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
48	rs181426108	chr4:3463032-3463033	Bivalent Enhancer ZNF genes & repeats Enhancers Flanking Active TSS Bivalent/Poised TSS	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
49	rs552558907	chr4:3463086-3463087	Bivalent Enhancer ZNF genes & repeats Enhancers Flanking Active TSS Bivalent/Poised TSS	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
50	rs562893891	chr4:3463142-3463143	Bivalent Enhancer ZNF genes & repeats Enhancers Flanking Active TSS Bivalent/Poised TSS	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:58)

Disease	PMID	Source
Retinitis pigmentosa	18421352	CNVD
Wolf-Hirschhorn syndrome	19259404	CNVD
Bladder cancer	19242612	CNVD
Breast cancer	19242612	CNVD
Congenital anomalies of the kidney and urinary tract	19242612	CNVD
abnormal development	18461090	CNVD
Olfactory neuroblastoma	18408657	CNVD
Wilms tumour	21544195	CNVD
Melanoma	20688739	CNVD
Colorectal cancer	16272173	CNVD
Non-syndromic sensorineural hearing loss	20606397	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Breast cancer	17603634	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Medulloblastoma	21979893	CNVD
Basal cell lymphoma	17053054	CNVD
Colorectal cancer	19359472	CNVD
Neuroblastoma	17533364	CNVD
head and neck squamous cell carcinoma	17671120	CNVD
Cancer	21637783	CNVD
Melanoma	21693616	CNVD
Squamous cell cancer	21044232	CNVD
Colorectal cancer	20709793	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Non-small cell lung cancer	21044232	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	17387387	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Glioblastoma multiforme	19960244	CNVD
Cervical cancer	21062161	CNVD
Gastrointestinal stromal cancer	16982739	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Glioblastoma multiforme	21080181	CNVD
Chordoma	21602918	CNVD
HIV/AIDS	22032296	CNVD
Neuroblastoma	18923191	CNVD
small cell lung cancer	20016488	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Urothelial carcinoma	21177765	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Lung cancer	18438408	CNVD
Prostate cancer	18632612	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Intellectual disability	22102821	CNVD
Autism	22495311	CNVD
Breast cancer	21785460	CNVD
Myelofibrosis	22110671	CNVD
Schizophrenia	21399695	CNVD
Pancreatic ductal adenocarcinoma	19077451	CNVD
Chronic lymphocytic leukemia	20421269	CNVD
Pancreatic cancer	17952125	CNVD
Breast cancer	21509527	CNVD
Ependymoma	20639864	CNVD
Non-syndromic sensorineural hearing loss	17122850	CNVD
Breast cancer	22522925	CNVD

Chromatin state (count:99 , 50 per page) page: 1 2

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr4:3454400-3462400	Weak transcription	HSMM	muscle
2	chr4:3454600-3462400	Weak transcription	Pancreas	Pancrea
3	chr4:3461000-3463000	Enhancers	Skeletal Muscle Female	skeletal muscle
4	chr4:3462000-3462400	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
5	chr4:3462000-3462800	Enhancers	Skeletal Muscle Male	skeletal muscle
6	chr4:3462000-3463800	Enhancers	HSMMtube	muscle
7	chr4:3462000-3464000	Enhancers	Fetal Muscle Leg	muscle
8	chr4:3462400-3463600	Enhancers	HSMM	muscle
9	chr4:3462400-3463800	Bivalent Enhancer	Fetal Muscle Trunk	muscle
10	chr4:3462400-3464800	Enhancers	Pancreas	Pancrea
11	chr4:3462600-3463200	ZNF genes & repeats	iPS DF 19.11 Cell Line	embryonic stem cell
12	chr4:3462600-3464000	Enhancers	Stomach Mucosa	stomach
13	chr4:3462600-3464200	Enhancers	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
14	chr4:3462600-3464200	Enhancers	Stomach Smooth Muscle	stomach
15	chr4:3462600-3464600	Enhancers	Gastric	stomach
16	chr4:3462600-3464600	Enhancers	Right Ventricle	heart
17	chr4:3462600-3464800	Bivalent Enhancer	Foreskin Keratinocyte Primary Cells skin03	Skin
18	chr4:3462600-3464800	Enhancers	Fetal Heart	heart
19	chr4:3462600-3464800	Enhancers	Left Ventricle	heart
20	chr4:3462600-3465000	Enhancers	HMEC	breast
21	chr4:3462600-3465800	Enhancers	Liver	Liver
22	chr4:3462800-3463000	Flanking Bivalent TSS/Enh	H1 Derived Mesenchymal Stem Cells	ES cell derived
23	chr4:3462800-3463000	Enhancers	Hela-S3	cervix
24	chr4:3462800-3463200	Bivalent Enhancer	NHEK	skin
25	chr4:3462800-3463400	Bivalent Enhancer	Foreskin Keratinocyte Primary Cells skin02	Skin
26	chr4:3462800-3463800	Enhancers	Breast Myoepithelial Primary Cells	Breast
27	chr4:3462800-3463800	Bivalent Enhancer	Muscle Satellite Cultured Cells	--
28	chr4:3462800-3463800	Enhancers	Aorta	Aorta
29	chr4:3462800-3463800	Enhancers	Esophagus	oesophagus
30	chr4:3462800-3464400	Enhancers	Lung	lung
31	chr4:3462800-3464800	Flanking Active TSS	Skeletal Muscle Male	skeletal muscle
32	chr4:3463000-3463200	Bivalent/Poised TSS	HepG2	liver
33	chr4:3463000-3463400	Enhancers	Ganglion Eminence derived primary cultured neurospheres	brain
34	chr4:3463000-3463400	Flanking Active TSS	Hela-S3	cervix
35	chr4:3463000-3464000	Enhancers	Duodenum Mucosa	Duodenum
36	chr4:3463000-3464000	Enhancers	Psoas Muscle	Psoas
37	chr4:3463000-3464800	Bivalent Enhancer	H1 Derived Mesenchymal Stem Cells	ES cell derived
38	chr4:3463000-3464800	Flanking Active TSS	Skeletal Muscle Female	skeletal muscle
39	chr4:3463200-3463400	Flanking Bivalent TSS/Enh	HepG2	liver
40	chr4:3463200-3463400	Flanking Bivalent TSS/Enh	NHEK	skin
41	chr4:3463200-3463600	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
42	chr4:3463200-3464200	Bivalent Enhancer	Colonic Mucosa	Colon
43	chr4:3463200-3464200	Enhancers	GM12878-XiMat	blood
44	chr4:3463200-3465600	Bivalent Enhancer	Placenta	Placenta
45	chr4:3463400-3463600	Flanking Bivalent TSS/Enh	Foreskin Keratinocyte Primary Cells skin02	Skin
46	chr4:3463400-3463600	Bivalent Enhancer	Fetal Stomach	stomach
47	chr4:3463400-3463800	Enhancers	Fetal Brain Male	brain
48	chr4:3463400-3463800	Bivalent Enhancer	HepG2	liver
49	chr4:3463400-3464200	Weak transcription	Ganglion Eminence derived primary cultured neurospheres	brain
50	chr4:3463400-3464800	Bivalent Enhancer	Primary B cells from peripheral blood	blood

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links